SWEDISH ORPHAN BIOVITRUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 281 SEK | +0.07% |
|
+7.66% | +5.24% |
Chart calendar Swedish Orphan Biovitrum AB
949d3c86d.yGxtb8BrN8L2NsESv5iRwUCfABWj_oMEB21Ijws5nA4.vAsMK_MvWvfPcbNeiM7OkBTVRyaSmOVtVhkO921brUifQQkOtD5lnadcpg~afe2e7c73468af956140005350cfaff9
Upcoming events on Swedish Orphan Biovitrum AB
Past events on Swedish Orphan Biovitrum AB
| 25/04/2024 07:30 pm | Q1 2024 Earnings Call |
| 25/04/2024 11:30 am | Q1 2024 Earnings Release |
| 08/02/2024 06:30 pm | Q4 2023 Earnings Call |
| 08/02/2024 02:52 pm | Q4 2023 Earnings Release |
| 09/12/2023 | American Society of Hematology Meeting |
| 02/11/2023 | American Society of Nephrology Kidney Week Meeting |
| 30/10/2023 05:30 pm | Q3 2023 Earnings Call |
| 30/10/2023 01:07 pm | Q3 2023 Earnings Release |
| 18/09/2023 06:30 pm | Investor Meeting - KOL |
| 28/08/2023 | Rights Issue: 1 new share @ 142 SEK for 7 existing shares |
| 15/08/2023 01:30 pm | Extraordinary Shareholders Meeting |
| 19/07/2023 07:00 pm | Investor Meeting - Key Opinion Leader |
| 18/07/2023 04:30 pm | Q2 2023 Earnings Call |
| 18/07/2023 02:09 pm | Q2 2023 Earnings Release |
| 29/06/2023 | Investor Meeting - Stiefel |
| 25/06/2023 | International Society on Thrombosis and Haemostasis Meeting |
| 10/05/2023 06:30 pm | Acquisition of CTI BioPharma Corp by Swedish Orphan Biovitrum AB Call |
| 09/05/2023 06:30 pm | Annual General Meeting |
| 27/04/2023 05:30 pm | Q1 2023 Earnings Call |
| 27/04/2023 12:04 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 14 248 14 210 0.26% | 15 261 15 155 0.7% | 15 529 15 338 1.24% | 18 790 18 363 2.32% | 22 123 21 968 0.71% | 24 709 |
|
EBITDA Million SEK | Released Forecast Spread | 6 121 6 302 -2.87% | 6 830 6 196 10.24% | 5 740 5 466 5.01% | 6 758 6 072 11.3% | 7 676 7 475 2.69% | 8 904 |
|
EBIT Million SEK | Released Forecast Spread | 4 533 4 774 -5.04% | 4 818 4 110 17.24% | 3 733 3 539 5.47% | 4 488 4 051 10.78% | 4 485 4 437 1.07% | 5 335 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 4 247 4 540 -6.46% | 4 217 3 562 18.38% | 3 295 3 108 6.03% | 3 321 3 270 1.56% | 2 954 3 399 -13.09% | 4 221 |
|
Net income Million SEK | Released Forecast Spread | 3 304 3 556 -7.08% | 3 245 2 743 18.31% | 2 679 2 375 12.8% | 2 638 2 620 0.69% | 2 409 2 695 -10.6% | 3 380 |
|
EPS SEK | Released Forecast Spread | 11,2 12,1 -6.99% | 10,9 9,25 17.9% | 9,03 8,01 12.75% | 8,84 8,84 0.01% | 7,39 8,46 -12.69% | 9,89 |
| Announcement Date | 13/02/20 | 18/02/21 | 10/02/22 | 08/02/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 4 925 4 470 10.17% | 3 876 3 533 9.72% | 3 999 3 905 2.41% | 5 991 5 512 8.7% | 5 239 5 142 1.89% | 4 872 4 403 10.66% | 5 168 4 628 11.66% | 6 844 6 735 1.62% | 6 256 5 805 7.77% | 5 254 | 5 795 | 7 285 | 6 570 | 6 146 |
|
EBITDA Million SEK | Released Forecast Spread | 1 461 1 608 -9.17% | 997 854 16.69% | 1 278 1 170 9.27% | 2 493 2 298 8.49% | 2 159 1 768 22.11% | 1 286 1 079 19.18% | 1 585 1 122 41.3% | 2 645 2 681 -1.34% | 2 377 2 015 17.97% | 1 398 | 2 040 | 3 075 | 2 713 | 2 476 |
|
EBIT Million SEK | Released Forecast Spread | 1 437 1 169 22.96% | 423 376 12.36% | 699 739 -5.42% | 1 916 1 764 8.6% | 1 495 1 208 23.75% | 413 531 -22.27% | 547 441 23.98% | 1 691 1 970 -14.16% | 1 468 1 114 31.78% | 347 | 1 197 | 2 343 | ||
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 674 1 061 -36.48% | 317 278 13.96% | 564 495 13.99% | 1 766 1 689 4.57% | 1 325 1 032 28.33% | 275 329 -16.51% | 116 239 -51.51% | 1 237 1 804 -31.41% | 982 811 21.04% | 263 | 819 | 1 879 | 1 589 | 1 384 |
|
Net income Million SEK | Released Forecast Spread | 543 909 -40.23% | 258 211 22.49% | 451 418 8.01% | 1 386 1 303 6.36% | 1 067 825 29.36% | 222 244 -9.04% | 94,0 192 -50.92% | 1 026 1 308 -21.53% | 800 644 24.19% | 174 | 667 | 1 421 | ||
|
EPS SEK | Released Forecast Spread | 1,83 3,28 -44.21% | 0,86 0,73 17.21% | 1,51 1,36 10.96% | 4,64 4,41 5.19% | 3,56 2,79 27.8% | 0,74 1,07 -30.52% | 0,30 0,45 -33.96% | 2,99 3,98 -24.86% | 2,33 1,76 32.33% | 0,68 | 1,75 | 4,32 | 3,55 | 3,09 |
| Announcement Date | 28/04/22 | 19/07/22 | 27/10/22 | 08/02/23 | 27/04/23 | 18/07/23 | 30/10/23 | 08/02/24 | 25/04/24 | - | - | - | - | - |
More events
Past sector events for Swedish Orphan Biovitrum AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SOBI Stock
- Calendar Swedish Orphan Biovitrum AB
